Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

April 28, 2023 updated by: Pierre Fabre Dermo Cosmetique

Determination of the Thickness Truly Applied of the SPRAY50+ on Different Areas of the Face Estimated by a Multispectral Imaging Method, After Application of the Product With and Without Recommendations of Use by a Group of Healthy Subjects

The aim of the study is to determine:

  • the thickness of the RV4369A truly applied on different areas of the face after single application of the product determined by a multispectral imaging method.
  • the influence of a second application of the product 15 to 30 minutes after the first application on the product thickness determined by multispectral imaging method.
  • the influence of the recommendations of use provided to the subjects before application of the product on the product thickness determined by multispectral imaging method .

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is a monocentric, comparative, open study performed on the face and forearms of healthy adults.

Planning of the visits:

Visit 1: Inclusion visit (D1) Visit 2: End of study visit (D10), a window of +/- 2 days is allowed for this evaluation, * The theoretical study duration for each subject is 10 days. The maximal study duration for each subject is 12 days.

Study Type

Observational

Enrollment (Actual)

26

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toulouse, France
        • Skin Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Panel of healthy volonteers

Description

Inclusion Criteria:

  • Dry, normal to combination skin
  • Phototype I to V inclusive.
  • Absence of significant facial hair.

Exclusion Criteria:

Population

  • Pregnant, breastfeeding women.
  • For men: moustached or bearded.
  • Substantial hair on the forearm and face.
  • Application of keratolytic or self-tanning products to the face, forearms and arms in the four weeks prior to inclusion.
  • With scars or other cutaneous characteristics, sunburn on forearms in the test areas, the size of which is considered incompatible with the study.
  • Application of water, cleansing or beauty products to the forearms and arms since the last wash on the evening before inclusion.

Diseases :

  • Known history of allergy to any of the investigational product ingredients.
  • Known history of allergy to latex.
  • Skin lesions or skin disease on the face or on the arms and forearms that may affect test results (seborrheic dermatitis, atopic dermatitis, psoriasis, acne, rosacea, etc.).

Treatments:

  • Ongoing local or Oral treatment (retinoids, anti-inflammatory) that may affect test results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Treated Group
all subjects will apply the study product RV4369A

The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer.

Application modalities:

Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits.

After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits.

Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities.

After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amounts of sun spray applied to the face, measured by multispectral imaging after single application by the subject
Time Frame: Visit 1 (Day 1)
The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique
Visit 1 (Day 1)
Amounts of sun spray applied to the face, measured by multispectral imaging after 2 applications by the subject
Time Frame: Visit 1 (Day 1)
The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique
Visit 1 (Day 1)
Amounts of sun spray applied to the face, measured by multispectral imaging after 1 application by the subject and according to the recommendations of use provided by the technician
Time Frame: Visit 2 (Day 10)
The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique
Visit 2 (Day 10)
Comparisons between measurements of sun spray amounts determined by multispectral imaging
Time Frame: Visit 1 (Day1) and visit 2 (Day 10)
Comparaisons between an application without recommendations of use (Visit 1), an application without recommendations followed by a second application (Visit 1) and an application according to the recommendations of use (Visit 2)
Visit 1 (Day1) and visit 2 (Day 10)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thérèse Nocera, MD, Pierre Fabre Dermo Cosmetique

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 4, 2022

Primary Completion (Actual)

April 29, 2022

Study Completion (Actual)

April 29, 2022

Study Registration Dates

First Submitted

April 19, 2023

First Submitted That Met QC Criteria

April 28, 2023

First Posted (Actual)

May 1, 2023

Study Record Updates

Last Update Posted (Actual)

May 3, 2023

Last Update Submitted That Met QC Criteria

April 28, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ADPROTECTPF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sunscreen

Clinical Trials on RV4369A cosmetic product

Subscribe